Article Versions Notes

Ezz Eldin RR, Saleh MA, Alwarsh SA, Rushdi A, Althoqapy AA, El Saeed HS, Abo Elmaaty A. RETRACTED: Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies. Pharmaceuticals. 2023; 16(9):1247. https://doi.org/10.3390/ph16091247

Ezz Eldin, Rogy R., Marwa A. Saleh, Sefat A. Alwarsh, Areej Rushdi, Azza Ali Althoqapy, Hoda S. El Saeed, and Ayman Abo Elmaaty. 2023. "RETRACTED: Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies" Pharmaceuticals 16, no. 9: 1247. https://doi.org/10.3390/ph16091247

Ezz Eldin, R. R., Saleh, M. A., Alwarsh, S. A., Rushdi, A., Althoqapy, A. A., El Saeed, H. S., & Abo Elmaaty, A. (2023). RETRACTED: Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies. Pharmaceuticals, 16(9), 1247. https://doi.org/10.3390/ph16091247